GenBody COVID-19 Ag

 

The GenBody rapid test (ref. 9432) identifies in a very short time period the presence of SARS-CoV-2 antigens, giving a qualitative definition of the viral infection. The high correlation of the test results with the outcome of the RT-qPCR tests makes the GenBody COVID-19 Ag the fast solution that can be also run as a point-of-care. The test can be performed without any specific laboratory equipment, although the reading can be eased by using Confiscope G20 portable device, for the automated interpretation of test results.


Main features
 

  • CE-IVD mark
  • Format: 25 tests
  • Sample: nasopharyngeal swab
  • Time to results: 15-20 min
  • Stability: 12 months
  • Optional automated reading and interpretation of results with Confiscope G20 device
  • Kit content:
    • Test cassettes individually foil-pouched
    • Extraction solution
    • Extraction tubes with disposable dropper cap
    • Sterilized nasopharyngeal swabs for sample collection
    • Instructions for use

This product is CE-IVD marked. Only for European Union market, not for US market.
 

CONFISCOPE G20

 

Confiscope G20 is a portable device for the automated reading and interpretation of the GenBody immunochromatographic rapid tests.


Main features
 

  • Easy to use
  • Portable (800 g)
  • Google Android 5.1 interface
  • Test reading time: 6 sec
  • QR code for lot calibration and registration
  • Database with more than 10,000 entries
  • Wi-Fi connectivy for software updates
 

Eurospital Spa - Via Flavia 122 - 34147 Trieste - P.IVA: 00047510326 - C.S. € 2582000 CF e Reg. Impr. 00047510326 - REA TS 38955
Eurospital © 2024 - Privacy - Site credits